PR Newswire Asia's news > Biotechnology

 < Previous page   |   Title only   |   Print    Next page > 
     
GC Biopharma Enhances IVIG Safety Profile with Advanced Prothrombotic Impurity Detection Technology
Proprietary analytical method for precise Factor XI (FXI) measurement published in the Journal of Microbiology and Biotechnology Novel IgG Blocker eliminates heterophilic antibody interference, ensuring ...
2026-04-06T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Fast-Acting Covalent Protein Drugs From a New High-Throughput Platform
HANGZHOU, China , April 3, 2026 /PRNewswire/ -- A team led by principal investigators Bobo Dang and Ting Zhou at Westlake University/Westlake Laboratory reported in Science a high-throughput platform ...
2026-04-03T    Biotechnology   Education   Health Care/Hospital   Publishing/Information Service 
Assembling Over 1,000 Human Genomes Affordably: New Method Powers Medicine's Future
HANGZHOU, China , April 3, 2026 /PRNewswire/ -- A research team led by Zhen-Xing Endowed Professor Jian Yang at the School of Life Sciences, Westlake University, together with collaborators, ...
2026-04-03T    Biotechnology   Health Care/Hospital   Higher Education   Medical/Pharmaceuticals 
Syneron Bio Announces Completion of $150 Million Series B Financing
BEIJING , April 3, 2026 /PRNewswire/ -- Syneron Bio, a leader in intelligent platform-driven macrocyclic peptide drug discovery, announced the successful closing of its Series B financing on March 31th. ...
2026-04-03T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Earendil Labs Announces First Patient Dosed in a Phase IIa Trial of a Half-life Extended Anti-TL1A Antibody (HXN-1001) in Patients with Ulcerative Colitis
WILMINGTON, Del. , April 2, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced the first patient has been dosed in a Phase ...
2026-04-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
StairMed Secures RMB 500 Million Financing Led by Alibaba, Joined by Tencent
SHANGHAI , April 2, 2026 /PRNewswire/ -- Shanghai StairMed Technology Co., Ltd. ("StairMed" or "the Company") recently announced the closing of a strategic financing round totaling ...
2026-04-02T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Caliway Selected to Present Preclinical Data on CBL-514 in Combination with GLP-1R Therapy at the American Diabetes Association's 2026 Scientific Sessions
Preclinical research on Caliway's fat reduction drug candidate CBL-514 in combination with GLP-1R-based weight-loss therapies has been selected for presentation at the American Diabetes Association's 2026 ...
2026-04-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Telix Appoints David Gill as Non-Executive Director
MELBOURNE, Australia and INDIANAPOLIS , April 2, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces the appointment of David Gill as a Non-Executive ...
2026-04-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Bambusa Therapeutics Presented Positive Results from the Phase 1 Multiple Ascending Dose Trial of BBT001 at the 2026 American Academy of Dermatology (AAD) Annual Meeting
- Bambusa's lead product candidate, BBT001 is a next-generation long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-31 for the treatment of atopic ...
2026-04-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Sino Biological ProPure™ Endotoxin-Free Proteins: The "Invisible Guardian" of Biopharmaceuticals
HOUSTON , April 1, 2026 /PRNewswire/ -- After months of meticulous work, your cells suddenly behave unpredictably, or your mouse models develop fever and systemic inflammation during critical studies. ...
2026-04-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.